 Michaela Dolan
Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 7 | 2021 | 785 | 0.710 |
Why?
| | HIV Envelope Protein gp120 | 5 | 2018 | 65 | 0.630 |
Why?
| | Structural Homology, Protein | 3 | 2012 | 24 | 0.550 |
Why?
| | Protein Conformation | 7 | 2018 | 864 | 0.510 |
Why?
| | Models, Molecular | 14 | 2018 | 1459 | 0.510 |
Why?
| | Computer Simulation | 6 | 2012 | 957 | 0.500 |
Why?
| | Proteins | 2 | 2012 | 954 | 0.490 |
Why?
| | Sequence Alignment | 4 | 2016 | 345 | 0.480 |
Why?
| | Algorithms | 2 | 2012 | 1618 | 0.440 |
Why?
| | env Gene Products, Human Immunodeficiency Virus | 2 | 2021 | 16 | 0.370 |
Why?
| | CD4 Antigens | 3 | 2018 | 123 | 0.350 |
Why?
| | Genome, Viral | 3 | 2018 | 131 | 0.340 |
Why?
| | Molecular Dynamics Simulation | 6 | 2017 | 214 | 0.320 |
Why?
| | Software | 2 | 2012 | 652 | 0.310 |
Why?
| | HIV Antibodies | 4 | 2021 | 51 | 0.300 |
Why?
| | Antibodies, Neutralizing | 4 | 2021 | 231 | 0.260 |
Why?
| | Viral Proteins | 3 | 2017 | 313 | 0.250 |
Why?
| | Amyloid | 2 | 2014 | 86 | 0.240 |
Why?
| | Nucleic Acid Conformation | 5 | 2013 | 683 | 0.230 |
Why?
| | Binding Sites | 7 | 2017 | 1248 | 0.230 |
Why?
| | Amino Acid Sequence | 9 | 2021 | 2113 | 0.230 |
Why?
| | Protein Binding | 7 | 2018 | 2017 | 0.220 |
Why?
| | Ebolavirus | 2 | 2013 | 33 | 0.220 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2001 | 526 | 0.210 |
Why?
| | RNA, Bacterial | 3 | 2001 | 183 | 0.200 |
Why?
| | Protein Stability | 2 | 2018 | 160 | 0.200 |
Why?
| | Escherichia coli | 3 | 2001 | 791 | 0.190 |
Why?
| | Peptide Fragments | 2 | 2016 | 715 | 0.190 |
Why?
| | Tyrosine | 3 | 2016 | 226 | 0.170 |
Why?
| | Protein Multimerization | 2 | 2017 | 166 | 0.170 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2018 | 40 | 0.170 |
Why?
| | Metalloporphyrins | 1 | 1998 | 108 | 0.160 |
Why?
| | Leukemia Virus, Murine | 1 | 2017 | 16 | 0.160 |
Why?
| | Leukemia, Experimental | 1 | 2017 | 28 | 0.160 |
Why?
| | Host Specificity | 1 | 2017 | 24 | 0.160 |
Why?
| | Tumor Virus Infections | 1 | 2017 | 57 | 0.160 |
Why?
| | Retroviridae Infections | 1 | 2017 | 46 | 0.160 |
Why?
| | Antigen Presentation | 2 | 2016 | 195 | 0.160 |
Why?
| | Molecular Sequence Data | 8 | 2016 | 2948 | 0.150 |
Why?
| | Protein Domains | 1 | 2018 | 216 | 0.150 |
Why?
| | RNA Viruses | 1 | 2017 | 30 | 0.150 |
Why?
| | Filoviridae Infections | 1 | 2016 | 4 | 0.150 |
Why?
| | Filoviridae | 1 | 2016 | 6 | 0.150 |
Why?
| | Norwalk virus | 1 | 2016 | 1 | 0.150 |
Why?
| | Molecular Mimicry | 1 | 2016 | 40 | 0.150 |
Why?
| | Receptors, CCR5 | 1 | 2016 | 54 | 0.150 |
Why?
| | Single-Chain Antibodies | 1 | 2016 | 13 | 0.140 |
Why?
| | Genome, Human | 1 | 2018 | 390 | 0.140 |
Why?
| | HLA-A2 Antigen | 1 | 2016 | 39 | 0.140 |
Why?
| | Immune Evasion | 2 | 2018 | 47 | 0.140 |
Why?
| | RNA, Viral | 2 | 2013 | 595 | 0.140 |
Why?
| | Adaptation, Biological | 1 | 2016 | 57 | 0.140 |
Why?
| | Viral Vaccines | 1 | 2017 | 95 | 0.140 |
Why?
| | Immunoglobulins | 1 | 2016 | 154 | 0.140 |
Why?
| | Capsid Proteins | 1 | 2016 | 111 | 0.140 |
Why?
| | Filaricides | 1 | 2015 | 2 | 0.140 |
Why?
| | Brugia malayi | 1 | 2015 | 4 | 0.140 |
Why?
| | Host-Pathogen Interactions | 1 | 2018 | 315 | 0.140 |
Why?
| | PrPSc Proteins | 1 | 2014 | 5 | 0.130 |
Why?
| | Prion Diseases | 1 | 2014 | 11 | 0.130 |
Why?
| | Acyltransferases | 1 | 2014 | 53 | 0.130 |
Why?
| | Prions | 1 | 2014 | 37 | 0.130 |
Why?
| | Epitopes | 1 | 2016 | 447 | 0.120 |
Why?
| | Antigens, Bacterial | 1 | 2014 | 125 | 0.120 |
Why?
| | RNA Editing | 1 | 2013 | 22 | 0.120 |
Why?
| | Cytidine Deaminase | 2 | 2011 | 58 | 0.120 |
Why?
| | Virus Replication | 2 | 2017 | 421 | 0.120 |
Why?
| | Receptors, Pattern Recognition | 1 | 2012 | 10 | 0.120 |
Why?
| | Codon | 2 | 2017 | 90 | 0.120 |
Why?
| | Base Sequence | 6 | 2017 | 2217 | 0.110 |
Why?
| | Lysine | 1 | 2014 | 246 | 0.110 |
Why?
| | Influenza, Human | 1 | 2018 | 556 | 0.110 |
Why?
| | Immunity, Innate | 1 | 2018 | 757 | 0.110 |
Why?
| | H-2 Antigens | 1 | 2012 | 111 | 0.110 |
Why?
| | Sterol 14-Demethylase | 1 | 2011 | 1 | 0.110 |
Why?
| | Antibodies, Viral | 1 | 2016 | 579 | 0.110 |
Why?
| | Drug Resistance, Fungal | 1 | 2011 | 9 | 0.110 |
Why?
| | Models, Chemical | 2 | 2008 | 272 | 0.110 |
Why?
| | Cryptococcus neoformans | 1 | 2011 | 16 | 0.110 |
Why?
| | Cryptococcosis | 1 | 2011 | 23 | 0.110 |
Why?
| | Databases, Protein | 1 | 2012 | 69 | 0.110 |
Why?
| | Cytosine Deaminase | 1 | 2011 | 14 | 0.100 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2011 | 43 | 0.100 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2012 | 174 | 0.100 |
Why?
| | DNA | 1 | 1998 | 1399 | 0.100 |
Why?
| | Interleukin-13 Receptor alpha1 Subunit | 1 | 2011 | 3 | 0.100 |
Why?
| | Ribosomes | 3 | 2001 | 138 | 0.100 |
Why?
| | Interleukin-13 Receptor alpha2 Subunit | 1 | 2011 | 6 | 0.100 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 2011 | 29 | 0.100 |
Why?
| | Protein Structure, Tertiary | 5 | 2016 | 833 | 0.100 |
Why?
| | Fungal Proteins | 1 | 2011 | 132 | 0.100 |
Why?
| | HIV Infections | 4 | 2021 | 2506 | 0.100 |
Why?
| | Viral Matrix Proteins | 1 | 2011 | 32 | 0.100 |
Why?
| | Antifungal Agents | 1 | 2011 | 140 | 0.100 |
Why?
| | Mycobacterium tuberculosis | 1 | 2014 | 309 | 0.100 |
Why?
| | Animals | 14 | 2018 | 34126 | 0.100 |
Why?
| | RNA, Messenger | 2 | 2013 | 2746 | 0.100 |
Why?
| | Interleukin-13 | 1 | 2011 | 129 | 0.090 |
Why?
| | Peptides | 1 | 2016 | 893 | 0.090 |
Why?
| | Interferon-alpha | 1 | 2011 | 191 | 0.090 |
Why?
| | HEK293 Cells | 3 | 2018 | 655 | 0.090 |
Why?
| | Bacterial Proteins | 2 | 2014 | 786 | 0.090 |
Why?
| | Membrane Proteins | 1 | 2016 | 1076 | 0.090 |
Why?
| | Recombinant Proteins | 2 | 2014 | 1332 | 0.090 |
Why?
| | RNA Interference | 1 | 2011 | 476 | 0.090 |
Why?
| | Protein Kinase Inhibitors | 1 | 2015 | 877 | 0.080 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 576 | 0.080 |
Why?
| | Crystallography | 1 | 2008 | 25 | 0.080 |
Why?
| | Mice, Inbred BALB C | 3 | 2017 | 1237 | 0.080 |
Why?
| | Protein Structure, Quaternary | 2 | 2018 | 118 | 0.080 |
Why?
| | BRCA1 Protein | 1 | 2007 | 58 | 0.080 |
Why?
| | Mice | 8 | 2017 | 15616 | 0.080 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2012 | 707 | 0.080 |
Why?
| | Neutralization Tests | 2 | 2018 | 71 | 0.070 |
Why?
| | Disease Models, Animal | 1 | 2016 | 3798 | 0.070 |
Why?
| | DNA Repair | 1 | 2007 | 204 | 0.070 |
Why?
| | Surface Plasmon Resonance | 2 | 2017 | 84 | 0.070 |
Why?
| | Cell Line | 3 | 2017 | 2814 | 0.070 |
Why?
| | Mutagenesis | 2 | 2017 | 182 | 0.070 |
Why?
| | Base Pairing | 2 | 2004 | 61 | 0.070 |
Why?
| | Tombusviridae | 1 | 2004 | 1 | 0.060 |
Why?
| | Water | 1 | 2008 | 437 | 0.060 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 1 | 2004 | 18 | 0.060 |
Why?
| | Vero Cells | 2 | 2017 | 68 | 0.060 |
Why?
| | Humans | 18 | 2021 | 121723 | 0.060 |
Why?
| | Macrophages | 1 | 2011 | 1328 | 0.060 |
Why?
| | Polymorphism, Genetic | 1 | 2007 | 664 | 0.060 |
Why?
| | Polysaccharides | 2 | 2014 | 87 | 0.060 |
Why?
| | Protein Structure, Secondary | 2 | 2014 | 343 | 0.060 |
Why?
| | Mutation | 3 | 2021 | 3516 | 0.060 |
Why?
| | Transcription Factors | 1 | 2011 | 1628 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2014 | 381 | 0.050 |
Why?
| | Crystallography, X-Ray | 2 | 2012 | 433 | 0.050 |
Why?
| | RNA, Transfer, Met | 1 | 2000 | 7 | 0.050 |
Why?
| | Peptide Initiation Factors | 1 | 2000 | 17 | 0.050 |
Why?
| | Amino Acid Motifs | 1 | 2021 | 207 | 0.050 |
Why?
| | Structure-Activity Relationship | 2 | 2012 | 533 | 0.050 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2021 | 179 | 0.050 |
Why?
| | Evolution, Molecular | 2 | 2017 | 463 | 0.050 |
Why?
| | DNA-Binding Proteins | 1 | 2007 | 1392 | 0.050 |
Why?
| | Pyrimidines | 2 | 2015 | 393 | 0.050 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 2 | 2016 | 244 | 0.050 |
Why?
| | Spectinomycin | 1 | 1999 | 2 | 0.050 |
Why?
| | Tetracycline | 1 | 1999 | 22 | 0.050 |
Why?
| | Spectrophotometry, Atomic | 1 | 1998 | 14 | 0.040 |
Why?
| | Intercalating Agents | 1 | 1998 | 5 | 0.040 |
Why?
| | Neuraminidase | 1 | 2018 | 27 | 0.040 |
Why?
| | Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2018 | 22 | 0.040 |
Why?
| | HIV Envelope Protein gp160 | 1 | 2018 | 7 | 0.040 |
Why?
| | HIV Antigens | 1 | 2018 | 17 | 0.040 |
Why?
| | Cations | 1 | 1998 | 80 | 0.040 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 1998 | 78 | 0.040 |
Why?
| | Circular Dichroism | 1 | 1998 | 140 | 0.040 |
Why?
| | Virus Internalization | 1 | 2018 | 49 | 0.040 |
Why?
| | AIDS Vaccines | 1 | 2018 | 44 | 0.040 |
Why?
| | Terminal Repeat Sequences | 1 | 2017 | 15 | 0.040 |
Why?
| | Sequence Homology | 1 | 2017 | 41 | 0.040 |
Why?
| | Antibodies, Monoclonal | 2 | 2016 | 1288 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2018 | 398 | 0.040 |
Why?
| | Receptors, Virus | 1 | 2017 | 81 | 0.040 |
Why?
| | Rabbits | 1 | 2018 | 771 | 0.040 |
Why?
| | Bronchi | 1 | 2018 | 249 | 0.040 |
Why?
| | RNA Splicing | 1 | 2018 | 253 | 0.040 |
Why?
| | Calicivirus, Feline | 1 | 2016 | 3 | 0.040 |
Why?
| | Open Reading Frames | 1 | 2017 | 124 | 0.040 |
Why?
| | Vaccines, Attenuated | 1 | 2017 | 115 | 0.040 |
Why?
| | Vaccines, Synthetic | 1 | 2017 | 127 | 0.040 |
Why?
| | Cryoelectron Microscopy | 1 | 2017 | 144 | 0.040 |
Why?
| | Guinea Pigs | 1 | 2016 | 153 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1998 | 532 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2016 | 100 | 0.040 |
Why?
| | Epitope Mapping | 1 | 2016 | 52 | 0.040 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2017 | 61 | 0.040 |
Why?
| | Cricetinae | 1 | 2016 | 274 | 0.040 |
Why?
| | Seasons | 1 | 2018 | 468 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 425 | 0.030 |
Why?
| | Capsid | 1 | 2016 | 103 | 0.030 |
Why?
| | Cattle | 1 | 1998 | 1019 | 0.030 |
Why?
| | Immunization | 1 | 2018 | 416 | 0.030 |
Why?
| | Virulence | 1 | 2016 | 251 | 0.030 |
Why?
| | Mesocricetus | 1 | 2014 | 34 | 0.030 |
Why?
| | Imatinib Mesylate | 1 | 2015 | 62 | 0.030 |
Why?
| | Inhibitory Concentration 50 | 1 | 2015 | 81 | 0.030 |
Why?
| | Polyelectrolytes | 1 | 2014 | 15 | 0.030 |
Why?
| | Dasatinib | 1 | 2015 | 47 | 0.030 |
Why?
| | Microscopy, Electron, Scanning Transmission | 1 | 2014 | 2 | 0.030 |
Why?
| | Carbon-13 Magnetic Resonance Spectroscopy | 1 | 2014 | 3 | 0.030 |
Why?
| | Cord Factors | 1 | 2014 | 4 | 0.030 |
Why?
| | Galactans | 1 | 2014 | 4 | 0.030 |
Why?
| | Carbohydrate Sequence | 1 | 2014 | 35 | 0.030 |
Why?
| | Static Electricity | 1 | 2014 | 116 | 0.030 |
Why?
| | RNA | 1 | 2001 | 859 | 0.030 |
Why?
| | Cell Wall | 1 | 2014 | 54 | 0.030 |
Why?
| | Thiazoles | 1 | 2015 | 124 | 0.030 |
Why?
| | Biocatalysis | 1 | 2014 | 67 | 0.030 |
Why?
| | Drosophila melanogaster | 1 | 2016 | 198 | 0.030 |
Why?
| | Benzamides | 1 | 2015 | 183 | 0.030 |
Why?
| | Disulfides | 1 | 2014 | 94 | 0.030 |
Why?
| | Larva | 1 | 2015 | 221 | 0.030 |
Why?
| | Proteolysis | 1 | 2014 | 142 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2014 | 204 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2014 | 382 | 0.030 |
Why?
| | Protein Folding | 1 | 2014 | 252 | 0.030 |
Why?
| | Kinetics | 1 | 2017 | 1698 | 0.030 |
Why?
| | Histocompatibility Antigen H-2D | 1 | 2012 | 21 | 0.030 |
Why?
| | beta 2-Microglobulin | 1 | 2012 | 42 | 0.030 |
Why?
| | Piperazines | 1 | 2015 | 327 | 0.030 |
Why?
| | 14-alpha Demethylase Inhibitors | 1 | 2011 | 1 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2018 | 986 | 0.030 |
Why?
| | Itraconazole | 1 | 2011 | 7 | 0.030 |
Why?
| | Fluconazole | 1 | 2011 | 16 | 0.030 |
Why?
| | APOBEC Deaminases | 1 | 2011 | 4 | 0.030 |
Why?
| | Voriconazole | 1 | 2011 | 26 | 0.030 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2011 | 23 | 0.030 |
Why?
| | Phenylalanine | 1 | 2011 | 67 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1648 | 0.030 |
Why?
| | Calmodulin | 1 | 2011 | 78 | 0.030 |
Why?
| | Blotting, Western | 1 | 2014 | 1226 | 0.020 |
Why?
| | APOBEC-3G Deaminase | 1 | 2010 | 6 | 0.020 |
Why?
| | Protein Array Analysis | 1 | 2011 | 63 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2011 | 116 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2011 | 310 | 0.020 |
Why?
| | Triazoles | 1 | 2011 | 136 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2010 | 64 | 0.020 |
Why?
| | Polymers | 1 | 2014 | 473 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2010 | 160 | 0.020 |
Why?
| | Gene Expression | 1 | 2016 | 1530 | 0.020 |
Why?
| | Ligands | 1 | 2012 | 556 | 0.020 |
Why?
| | Animals, Wild | 1 | 2010 | 55 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2014 | 1107 | 0.020 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2011 | 140 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2011 | 309 | 0.020 |
Why?
| | Anti-HIV Agents | 1 | 2016 | 675 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 1999 | 1491 | 0.020 |
Why?
| | Virulence Factors | 1 | 2011 | 144 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2011 | 663 | 0.020 |
Why?
| | Selection, Genetic | 1 | 2010 | 254 | 0.020 |
Why?
| | Anti-Retroviral Agents | 1 | 2010 | 205 | 0.020 |
Why?
| | X-ray Repair Cross Complementing Protein 1 | 1 | 2007 | 8 | 0.020 |
Why?
| | Porosity | 1 | 2008 | 89 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2008 | 149 | 0.020 |
Why?
| | NF-kappa B | 1 | 2011 | 672 | 0.020 |
Why?
| | Survival Rate | 1 | 2011 | 1828 | 0.020 |
Why?
| | Ultraviolet Rays | 2 | 2000 | 410 | 0.020 |
Why?
| | Genotype | 1 | 2011 | 1952 | 0.020 |
Why?
| | Transcription, Genetic | 2 | 2004 | 1403 | 0.020 |
Why?
| | Female | 3 | 2018 | 63833 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 2004 | 215 | 0.020 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2004 | 90 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2499 | 0.010 |
Why?
| | Prokaryotic Initiation Factor-3 | 1 | 2000 | 6 | 0.010 |
Why?
| | Alkalies | 1 | 2000 | 8 | 0.010 |
Why?
| | Anticodon | 1 | 2000 | 20 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2010 | 5052 | 0.010 |
Why?
| | Ribosomal Proteins | 1 | 2000 | 70 | 0.010 |
Why?
| | Hydrolysis | 1 | 2000 | 183 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2004 | 1212 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 337 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2007 | 2377 | 0.010 |
Why?
| | Signal Transduction | 1 | 2011 | 4810 | 0.010 |
Why?
| | RNA-Binding Proteins | 1 | 2000 | 386 | 0.010 |
Why?
| | Male | 1 | 2015 | 60425 | 0.010 |
Why?
|
|
Dolan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|